ResMed | RMD - Current Assets


ResMed reported $4.06B in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Ansell USD 1.11B 5.2M Dec/2025
Artivion USD 357.52M 566K Mar/2026
AtriCure USD 313.69M 8.82M Mar/2026
Baxter International USD 6.85B 25M Mar/2026
Cochlear AUD 1.37B 43.9M Dec/2025
Cooper Companies USD 2.3B 166M Mar/2026
CSL USD 11.85B 1000K Dec/2025
Dexcom USD 4.33B 298.4M Mar/2026
Edwards Lifesciences USD 6.23B 510.2M Mar/2026
Fisher Paykel Healthcare NZD 1.15B 168.5M Jun/2026
Globus Medical USD 2.2B 72.51M Mar/2026
Haemonetics USD 834.88M 108.8M Mar/2026
Idexx Laboratories USD 1.45B 40.25M Mar/2026
Inogen USD 203.72M 594K Sep/2025
Insulet USD 1.71B 204.5M Mar/2026
Integra LifeSciences USD 1.17B 12.47M Mar/2026
Intuitive Surgical USD 12.33B 807.5M Jun/2026
Medtronic USD 24.07B 75M Dec/2025
Philips EUR 9.78B 148M Mar/2026
Ramsay Health Care AUD 3.56B 480.3M Dec/2025
ResMed USD 4.06B 245.26M Mar/2026
Sigma Healthcare AUD 2.91B 2B Dec/2025
Sonic Healthcare AUD 2.3B 52.76M Dec/2024
Steris USD 2.39B 108.4M Mar/2026
Teleflex USD 1.86B 78.67M Mar/2026
Thermo Fisher Scientific USD 22.32B 6.39B Mar/2026